# Rongshujia

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/rongshujia

- Industry: Healthcare
- Headquarters: Shanghai, China
- Website: www.rsjia.com
- Total disclosed funding: $22M
- Latest round: Series A (Oct 10, 2022)
- Investors on record: 1

## About

Founded in 2019 and based in Shanghai, China, Rongshujia is a Chinese medicine chain brand that provides AI diagnosis and treatment systems and systematic operation solutions for the clinic industry. The company has 3 invention patents, 33 core intellectual property rights, and 1 work copyright. In 2015, the construction of the traditional Chinese medicine planting base was started. As of 2022, it has set up provincial operating subsidiaries in 18 provinces across the country and has deployed more than 700 TCM clinics across the country. In March 2024, it closed a series B funding.

The company is committed to AI-assisted diagnosis and treatment, health record management, sub-health conditioning, and other business. The main product is the Suling AI-assisted diagnosis system, which provides services such as auxiliary inquiries, analysis of causes, and auxiliary prescriptions.

The company will use the series B funds to expand the scale of offline clinics,  increase the integration of authentic medicinal herbs in the supply chain of Chinese medicine, increase the investment of AI diagnosis and treatment in clinical and effect evaluation, and promote the application of digital Chinese medicine in primary healthcare services.

## Funding rounds

- Series A, Oct 10, 2022, $22M — ChinaEquity Group

## Investors

- ChinaEquity Group (https://capitalatlas.ai/funds/chinaequity-group) — Series A